Table: Kaken Pharmaceutical -Q1 group results

KAKEN PHARMACEUTICAL

03/08/2016 05:30

Aug 3 (Reuters)-  
             Kaken Pharmaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 3 months ended      3 months ended       Year to  
                Jun 30, 2016        Jun 30, 2015     Mar 31, 2017  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             26.23               27.63           106.10     
                 (-5.1 pct)          (+28.7 pct)      (-3.3 pct)   
  Operating          8.10                9.23            28.90     
                 (-12.3 pct)        (+126.0 pct)      (-17.8 pct)  
  Recurring          8.22                9.36            29.10     
                 (-12.2 pct)        (+130.9 pct)      (-17.7 pct)  
  Net                5.80                6.30            20.80     
                 (-8.0 pct)         (+139.5 pct)      (-1.6 pct)   
  EPS            140.05 yen          152.09 yen       505.78 yen   
  Ann Div                                             150.00 yen   
  -Q2 div                             34.00 yen        75.00 yen   
  -Q4 div                             78.00 yen        75.00 yen   
   
  NOTE - Kaken Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4521.T  
  ((Tokyo Headline News Desk +813 6441 1812))